StockNow
Calendar
Log in
U.S. Markets

Moderna Inc. (MRNA) Q3 2026 (USD): EPS 0.38 (exp. -1.10), Revenue 1.3bln (exp. 890mln). FY revenue growth seen between 15-20%.

ORIGINAL · NewsquawkModerna Inc. (MRNA) Q3 2026 (USD): EPS 0.38 (exp. -1.10), Revenue 1.3bln (exp. 890mln). FY revenue growth seen between 15-20%.
StockNow breaking-news AI analysis

The breaking-news headline reports Moderna Q3 2026 EPS and revenue above stated expectations; retrieved evidence includes no supporting results-release details.

1 stocks
MRNAModerna, Inc. Common Stock$250.86Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Commodities

[MARKET UPDATE] Crude benchmarks dip as markets digest a Qatar Emir-US President Trump phone call; the broader risk tone stabilises with European equity futures pausing their downside

Geopolitics

The US and Iran are reportedly moving closer to a potential agreement to end the war, according to Bloomberg

Geopolitics

Iranian lawmaker warns that Iran's response to America will include Europe, Tasnim reports; the response could lead to oil crossing the USD 150 mark